Employing a mouse endotoxic shock model, recombinant MIF was found to greatly enhance lethality when coinjected with lipopolysaccharide (endotoxin), whereas an anti-MIF antibody conferred full protection against lethal endotoxemia. This evidence concerns the gene MIF and serum lipopolysaccharide activity.